Stay updated with breaking news from Aditxt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Dean Seal Shares of Aditxt and Evofem Biosciences soared after the companies signed a $100 million acquisition deal. Aditxt's stock was up 85% at $7.03 in...
Aditxt (NASDAQ:ADTX – Free Report) had its price objective increased by HC Wainwright to $61.00 in a research report sent to investors on Wednesday morning, Benzinga reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Aditxt’s Q3 2023 earnings at ($7.98) EPS, Q4 2023 earnings at ($4.47) […]
By Dean Seal Shares of Aditxt sank in premarket trading Friday after the company priced its private placement for proceeds of $10 million. The stock lost 44%...
Shares of Aditxt, Inc. (ADTX) are down more than 44 percent on Friday morning trade after the company decided to privately place 1,000,000 shares of $10 each amounting to $10 million.
Adimune, Inc. is nearing completion of its pre-clinical package for the immunotherapy clinical study drug candidate ADI-100 Collaboration will initially target Stiff Person Syndrome, a rare,... | May 5, 2023